Skip to main content

Pazopanib News

FDA Approves Votrient for Advanced Soft Tissue Sarcoma

April 26, 2012 – The U.S. Food and Drug Administration today approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who have previously received chemotherapy. Soft tissue...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Renal Cell Carcinoma

Pazopanib patient information at Drugs.com